Patents by Inventor Andrew J. Gmitter

Andrew J. Gmitter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240041882
    Abstract: The present invention relates to oral dosage forms comprising letermovir and, in particular, to compressed mini-tablets comprising letermovir. The invention also relates to methods of using the oral dosage forms for the treatment, prevention, or prophylaxis of HCMV in a patient. In addition, the invention also provides methods for making the mini-tablets of the invention.
    Type: Application
    Filed: December 14, 2021
    Publication date: February 8, 2024
    Applicant: Merck Sharp & Dohme LLC
    Inventors: Cory Bottone, Andrew J. Gmitter, Ashley R. Johnson, Eric A. Kemp, Feng Li, Fochive Njikam, Michael H. Wang
  • Patent number: 10734683
    Abstract: Electrolytes for use in commercially viable, rechargeable lithium metal batteries are described. The electrolytes contain one or more lithium salts, one or more organic solvents, and one or more additives. The electrolytes allow for reversible deposition and dissolution of lithium metal. Specific additives or additive combinations dramatically improved cycle life, decrease cell swelling, and/or lower cell impedance.
    Type: Grant
    Filed: August 14, 2017
    Date of Patent: August 4, 2020
    Assignee: Viking Power Systems Pte. Ltd.
    Inventors: Robert Jilek, Robert Ellis Doe, David Eaglesham, Andrew J. Gmitter, Jocelyn M. Newhouse, Matthew Trahan
  • Publication number: 20180048025
    Abstract: Electrolytes for use in commercially viable, rechargeable lithium metal batteries are described. The electrolytes contain one or more lithium salts, one or more organic solvents, and one or more additives. The electrolytes allow for reversible deposition and dissolution of lithium metal. Specific additives or additive combinations dramatically improved cycle life, decrease cell swelling, and/or lower cell impedance.
    Type: Application
    Filed: August 14, 2017
    Publication date: February 15, 2018
    Applicant: Pellion Technologies, Inc.
    Inventors: Robert Jilek, Robert Ellis Doe, David Eaglesham, Andrew J. Gmitter, Jocelyn M. Newhouse, Matthew Trahan
  • Publication number: 20180048017
    Abstract: Electrolytes for use in commercially viable, rechargeable lithium metal batteries are described. The electrolytes contain one or more lithium salts, one or more organic solvents, and one or more additives. The electrolytes allow for reversible deposition and dissolution of lithium metal. Specific additives or additive combinations dramatically improved cycle life, decrease cell swelling, and/or lower cell impedance.
    Type: Application
    Filed: August 14, 2017
    Publication date: February 15, 2018
    Applicant: Pellion Technologies, Inc.
    Inventors: Robert Jilek, Robert Ellis Doe, David Eaglesham, Andrew J. Gmitter, Jocelyn M. Newhouse, Matthew Trahan